title: Treatment options for anisohyperopia.
abstract: To investigate the success of conventional methods in the treatment of anisohyperopic amblyopia.
  
  
  
  A retrospective chart review of all patients with anisohyperopic amblyopia seen at the UCSD/ Ratner Children's Eye Center during a 42-month period was performed. The charts of 35 patients aged 3 to 14 years (mean age, 6.8 years) with 1.5 to 6.5 diopters of anisohyperopia were reviewed. Main outcome measures were the difference in refractive error and the pre- and post-treatment Snellen equivalent distance acuities. Treatment consisted of one or a combination of the following: spectacles, contact lenses, patching, and atropine. Binocularity was determined using the Titmus test. Compliance to treatment also was rated.
  
  
  
  Thirteen (37.1%) patients were treated with spectacles alone, 11 (31.5%) were treated with a combination of atropine and patching, 8 (22.8%) were treated with patching alone, 2 (5.7%) received blurring contact lenses, and 1 (2.9%) patient was treated with atropine alone. The average pretreatment visual acuity was 20/108, with an improvement to an average of 20/27 at the termination of treatment. Ninety-four percent of the patients obtained a visual acuity of 20/40 or better.
  
  
  
  Conventional methods of treatment are effective in improving vision and binocular status in anisohyperopia. Depending on the patient, only spectacles may be required.
authors.affiliation: Department of Ophthalmology, UCSD/Ratner Children's Eye Center, University of California, San Diego, California 92093-0946, USA.
authors.forename: David B
authors.initials: DB
authors.lastname: Granet
authors.forename: William
authors.initials: W
authors.lastname: Christian
authors.forename: Cintia E
authors.initials: CE
authors.lastname: Gomi
authors.forename: Lydia
authors.initials: L
authors.lastname: Banuelos
authors.forename: Erika
authors.initials: E
authors.lastname: Castro
mesh_terms: D000293:Adolescent; D000550:Amblyopia / Q000628:therapy; D015858:Anisometropia / Q000628:therapy*; D001285:Atropine / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003261:Contact Lenses; D005139:Eyeglasses; D006801:Humans; D006956:Hyperopia / Q000628:therapy*; D009184:Mydriatics / Q000627:therapeutic use*; D012189:Retrospective Studies; D012683:Sensory Deprivation; D016896:Treatment Outcome; D015348:Vision, Binocular / Q000502:physiology
chemical_list: D009184:Mydriatics; D001285:Atropine